Please login to the form below

Not currently logged in
Email:
Password:

crenezumab

This page shows the latest crenezumab news and features for those working in and with pharma, biotech and healthcare.

Glimmer of hope for amyloid drugs in Alzheimer's?

Glimmer of hope for amyloid drugs in Alzheimer's?

another amyloid-targeting drug called crenezumab heading into phase III testing after mixed results in earlier trials.

Latest news

  • Double trial disappointment for Roche Double trial disappointment for Roche

    The company also has two other investigational medicines for the disease in phase II development: crenezumab, another anti-amyloid antibody, and RG1577, a monoamine oxidase-B inhibitor.

  • Mixed findings for Roche in Alzheimer's study Mixed findings for Roche in Alzheimer's study

    Mixed findings for Roche in Alzheimer's study. Crenezumab misses targets but shows some signs of activity. ... Roche's candidate drug for Alzheimer's disease (AD) crenezumab missed its targets in a phase II trial, but showed some signs of activity in

  • Alzheimer's disease pipeline takes multiple hits Alzheimer's disease pipeline takes multiple hits

    in the EU, USA and South America); crenezumab (Genentech) that is being investigated in a long-term safety extension of phase II trials and a landmark AD prevention trial (see later); ... The first trial (organised by the Banner Alzheimer's Institute in

  • FDA explains draft Alzheimer's guidance in NEJM editorial FDA explains draft Alzheimer's guidance in NEJM editorial

    Lilly is also looking at earlier-stage intervention with solanezumab, while Genentech/AC Immune are going even further upstream by testing their crenezumab candidate in a healthy group of high-risk

  • FDA proffers guidance for new Alzheimer's drugs FDA proffers guidance for new Alzheimer's drugs

    Meanwhile, Roche subsidiary Genentech has gone one step further with its crenezumab candidate, licensed from AC Immune, and will test the therapy in a healthy group of patients who are genetically

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics